About
EnChannel Medical Ltd is a cardiac technology company founded in 2020, specializing in electrophysiology. Based in Guangzhou, China, with a subsidiary in Irvine, California, the company develops innovative solutions for treating complex cardiac arrhythmias, particularly atrial fibrillation. The company offers advanced technologies, including the DePolar™ mapping system and the NanoAblate™ pulsed-field ablation platform. These systems feature full-chamber 5D action-potential mapping, hybrid magnetic and impedance navigation, and integrated mapping capabilities. The third-generation pulsed-field ablation technology enhances safety and effectiveness in ablation procedures, supported by AI-based algorithms that improve mapping accuracy and clinical workflow. EnChannel Medical serves cardiac electrophysiologists and patients by providing efficient diagnostic and therapeutic tools. The company has garnered significant funding to support its product development and clinical trials, reflecting strong investor confidence in its innovative approach to improving patient outcomes in cardiac care.
Technologies
Keywords
Company Information
-
Employees 26
-
Founded 2020
Location
173 Technology Dr, Irvine, California, United States, 92618-2426